Lumosa Therapeutics Co., Ltd. (TPEX:6535)
Taiwan · Delayed Price · Currency is TWD 151.00
-1.00 (-0.66%)
Mar 13, 2026, 1:30 PM CST
Lumosa Therapeutics Revenue
In the year 2025, Lumosa Therapeutics had annual revenue of 35.83M TWD, down -8.49%. Lumosa Therapeutics had revenue of 13.05M in the quarter ending December 31, 2025, a decrease of -34.11%.
Revenue
35.83M
Revenue Growth
-8.49%
P/S Ratio
705.82
Revenue / Employee
n/a
Employees
43
Market Cap
25.29B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 35.83M | -3.32M | -8.49% |
| Dec 31, 2024 | 39.15M | -17.76M | -31.21% |
| Dec 31, 2023 | 56.92M | 30.27M | 113.63% |
| Dec 31, 2022 | 26.64M | 9.28M | 53.45% |
| Dec 31, 2021 | 17.36M | -4.29M | -19.81% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sunmax Biotechnology | 2.00B |
| Ever Supreme Bio Technology | 1.01B |
| EirGenix | 936.18M |
| TCM Biotech International | 682.40M |
| TaiMed Biologics | 607.22M |
| Medigen Vaccine Biologics | 594.96M |
| Oneness Biotech | 117.33M |
| Polaris Group | 70.83M |